Navigate Up
Sign In

Franciscan Union ACO

​Franciscan Union ACO
700 E. Southport Road
Indianapolis, IN 46227
1 (855) 268-9086

ACO Primary Contact
Untitled Document

Public Reporting

Composition of ACO:

LLC with Hospital, Outpatient Centers and ACO providers

ACO Participants

Franciscan Union ACO Governing Body

Name Title​ Responsibilities​ Member Type​ ACO Participant Legal Name​
Tomchaney, Albert Chief Medical Officer Leadership,  Corporate Affairs, and Clinical Operations ACO Participant Franciscan St. Francis Health
Brehm, Jay Executive Vice President & Regional Chief Financial Officer Leadership & Financial Operations ACO Participant Franciscan St. Francis Health
Brody, Robert J. President & Chief Executive Officer Leadership,  Corporate Affairs, and Governance ACO Participant Franciscan St. Francis Health
Andreasen, Hans, MD Medical Director   ACO Participant Union Associated Physician Clinic
Hayes, Virginia Director of Administrative Services   ACO Participant Providence Medical Group, LLC
Bittar, George, MD Chief Executive Officer   ACO Participant Providence Medical Group, LLC
Bolinger, James, DO Vice President Medical Affairs   ACO Participant Union Hospital
Board, Pat Chief Executive Officer   ACO Participant Union Health System
Hulman, Steve
President   ACO Participant Union Hospital
Christee, James W. Medicare board member  
 
 

Franciscan Union ACO Committees and Key Leadership Personnel

Members of the ACO’s Professional Services Committee include:
  • John Bolinger, DO, Committee Chair
  • Joseph Larosa, MD, Committee Member
  • Hans Andresean, MD, Committee Member
  • Steve Holman, Committee Member
  • Pat Board, Committee Member

Finance and Operations Committee include:

  • Jay Brehm, Committee Chair
  • Wayne Hutson, Committee Member
  • Michael Resener, Esq., Committee Member
  • Mike Fouty, Committee Member

Aggregate Amount of Shared Savings/Losses

Performance Year 1/2013: $0
Performance Year 2/2014: $0​
Performance Year 3: TBD

How Shared Savings Are Distributed

The ACO’s shared savings model includes both reinvestment in ACO infrastructure and payments to ACO participants to help coordinate care for Medicare Fee-for-Service beneficiaries.

33% of shared savings will be invested in ACO infrastructure, 33% will go to hospital facilities, and 33% will go to providers.


Quality Performance Results

Measure number​               ​Performance Measure​        2013 Reporting Period 
        
                           ​
2014 Performance Summary Statistics ​


ACO Performance Rate Mean Performance Rate for All ACOs​
    ACO Performance Rate
    Mean Performance Rate for All ACOs​
​(ACO-1) ​Getting Timely Care, Appointments, and Information  ​83.04 ​80.13
​(ACO-2) ​How Well Your Doctors Communicate  ​92.86 ​92.39
​(ACO-3) ​Patients’ Rating of Doctor  ​92.75 ​91.58
​(ACO-4) ​Access to Specialists
​87.42 ​83.97
​(ACO-5) ​Health Promotion and Education  ​51.09 ​58.29
​(ACO-6) ​Shared Decision Making  ​72.97 ​74.6
​(ACO-7) ​Health Status/Functional Status
​72.92 ​71.1
(ACO-8)​ ​Risk Standardized, All Condition Readmissions  ​14.59 ​14.90 ​15.36 ​15.15
​(ACO-9) ​ASC Admissions: COPD or Asthma in Older Adults  ​1.36 ​1.17
    ​1.15
​1.08
(ACO-10)​ ​ASC Admission: Heart Failure  ​1.17 ​1.20
    .95
​1.19
​(ACO-11) ​Percent of Primary Care Providers who Qualified for EHR Incentive Payment  ​72.00% ​ 66.21%​
    78.57%
​76.71%
​(ACO-12) ​Medication Reconciliation  ​99.70 ​82.61
(ACO-13)​ ​Falls: Screening for Fall Risk  ​ 42.62 ​45.6
​(ACO-14)​ ​Influenza Immunization  ​62.44 ​57.51
​(ACO-15) ​Pneumococcal Vaccination  ​62.77 ​55.03
​(ACO-16) ​Adult Weight Screening and Follow-up

​49.34 ​66.75
(ACO-17)​ ​Tobacco Use Assessment and Cessation Intervention  ​98.01 ​86.79
​(ACO-18) ​Depression Screening   ​41.00 ​39.27
​(ACO-19) ​Colorectal Cancer Screening  ​57.68 ​56.14
​(ACO-20) ​Mammography Screening  ​65.30 ​61.41
​Proportion of Adults who had blood pressure screened in past two years ​99.67 ​60.24
​Beneficiaries with diabetes who met all of the following criteria ​28.97 ​25.41
​(ACO-22) ​Hemoglobin A1c Control (HbA1c)
(<8 percent) 
​72.52 ​Not available
​(ACO-23) ​Low Density Lipoprotein (LDL) (< 100 mg/dL)  ​55.30 ​Not available
​(ACO-24) ​Blood Pressure (BP) < 140/90  ​69.04 ​Not available
​(ACO-25) ​Tobacco Non-Use  ​96.19 ​Not available
​(ACO-26) ​Aspirin Use     ​89.60 ​Not available
​(ACO-27) ​Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent)  ​16.56​ ​20.35
​(ACO-28) ​Percent of beneficiaries with hypertension whose BP < 140/90  ​67.70 ​68.02
​(ACO-29) ​Percent of beneficiaries with IVD with complete lipid profile and LDL control < 100mg/dl  ​47.80 ​57.29
​(ACO-30) ​Percent of beneficiaries who use Aspirin or other antithrombotic  ​ 88.51 ​80.79
​(ACO-31) ​Beta-Blocker Therapy for LVSD ​95.00 ​82.71
​Percent of beneficiaries with CAD who met all of the following criteria ​62.30 ​66.9
​(ACO-32) ​Drug Therapy for Lowering LDL-Cholesterol   67.38 ​Not available
 (ACO-33)​ ​(ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) ​80.00 ​Not available
 




​​​​